Skip to content

Moxibustion for pre & stage 1 hypertension patients

Moxibustion for pre & stage 1 hypertension: a pilot randomized controlled open trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000572
Enrollment
40
Registered
2012-11-08
Start date
2011-09-29
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Moxibustion group: 2 times/week, for 8 weeks Control group: exercise and diet control

Sponsors

Korea Institute of Oriental Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patient age between 19 and 65 years 2. Prehypertension or stage 1 hypertension (SBP 120 to 159, DBP: 80 to 99) according to JNC7 criteria 3. Patients who give written, informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who take prescription or OTC medication or herb/supplement for controlling blood pressure 2. Secondary blood pressure patients 3. Cerebrovascular or cardiovascular disease history 4. Malignant cancer history 5. Diabetes patients who currently need insulin injection or diabetic medications 6. Several disease history: renal diseases, hepatic diseases, thyroid diseases, active Tbc and other infectious diseases 7. Hemorrhagic diseases or patients who take anti-coagulants (except aspirin) 8. Patients who have T-needle allergy 9. Local infection at ear 10. Participants who have systemic steroid therapy or immune depressants 12. Participants who take medications which may affect blood pressure such as oral anticeptives, central nervous system depressants or stimulants 13. Pregnant or breast-feeding women or women who have plan to be pregnant 14. Participants who used traditional Korean medicinal treatment during last 1 months 15. Participants who are unappropriate to this trial due to other reasons, decided by researchers

Design outcomes

Primary

MeasureTime frame
Average systolic and diastolic blood pressure

Secondary

MeasureTime frame
Safety assessment;Mean arterial pressure;Body mass index;Lipid profile and hs-CRP;The change of blood pressure before and after moxibustion treatments in treatment group;Questinnaire of pattern indentificatiion

Countries

Korea, Republic of

Contacts

Public ContactKyung-Won Kang

Korea Institute of Oriental Medicine

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026